Watch the video
Transforming Early Life Nutrition
dsm-firmenich's HMO platform offerings are supported by the latest preclinical and clinical data. These innovative solutions are designed to help you formulate purpose-led products that effectively support key health outcomes in infants, children and across the lifespan. In addition, you can rely on our deep regulatory expertise to navigate safety and approval procedures with speed and confidence.
HMOs and their benefits
Human Milk Oligosaccharides (HMOs) are a collection of carbohydrate structures and the third most abundant solid component in human milk after lipids and lactose.[1] Clinical and preclinical research has shown that HMOs may help to optimize microbiota development in infants by nourishing beneficial bacteria such as bifidobacteria – one of the most abundant microbial genera present in the intestine of a full-term, breast-fed, healthy newborn. [2] A healthy gut microbiota could in turn help to protect against harmful microbes and support healthy immune system development.[3] HMOs are an important component of human milk, which is the gold standard for infant nutrition.[4] However, HMOs can also be synthetically incorporated into formula milk as a nutritional and functional ingredient.
- At least200different HMOs have been identified in human milk[5]
- HMOs act as prebiotic agents to promote optimal microbiota development in infants[6]
- HMOs may directly and indirectly influence overall infant health and development[7],[8],[9]
Play
At least200different HMOs have been identified in human milk[1]
HMOs act as prebiotic agents to promote optimal microbiota development in infants[1]
HMOs may directly and indirectly influence overall infant health and development[1],[2],[3]
LEARN MORE ABOUT OUR HMO PRODUCT PORTFOLIO FOR THE DIETARY SUPPLEMENTS MARKET
Human Milk Oligosaccharides:
a key component of human milk
Recently, more evidence has become available on the effect that HMOs in combination can have on infant growth, health, and development.
The latest clinical data suggests that infant formulas supplemented with 5 HMOs can help support a healthier and stronger immune system through the gut. Read more in our latest download.
Download detail AID
Watch our videos on harnessing the power of HMOs to innovate in early life nutrition
Here at dsm-firmenich, we believe in offering science backed solutions to help babies around the world to lead a brighter life. Thanks to new advances in science, the emerging health benefits of HMOs can be leveraged to support infants throughout the first thousand days. Learn more about how dsm-firmenich can support your ambitions in early life nutrition with its industry-leading capabilities.
Harnessing the Power of HMOs in Early Life Nutrition
Watch our latest webinar with dsm-firmenich experts and discover strategies to tap into the emerging science around HMOs, leverage the global trends insights shaping the future of ELN innovation and hear the latest updates on HMO regulatory approvals across EMEA.
Building a Foundation for Infants' Health with HMO Innovations
Watch our Q&A panel discussion that we hosted at ESPGHAN 2023, with expert insights from Dr. Lars Bode, Director of the Human Milk Institute at the University of California, and Niels Banke, Chief Scientific Officer for HMOs at dsm-firmenich.
Whitepaper: HMOs – Inspired by Nature, Supported by Science
The emerging science behind HMOs suggests potentially wide-ranging health benefits in and beyond infancy. Download our whitepaper to discover the key mechanisms of action and latest insights on how HMOs may positively impact infant health.
Download whitepaper
Our HMO products
dsm-firmenich offers one of the broadest portfolios of commercially-available HMOs suitable for a range of applications, and our products are approved foruse in more than 160 countries. Offering straight and premix capabilities for HMOs as well as market-ready solutions to help you bring your next innovation to consumers faster, we’re your end-to-end partner in developing purpose-led products.
GlyCare™ 2FL
Learn more
GlyCare™ LNnT
Learn more
GlyCare™ 2FL/DFL
Learn more
Glycare™ LNT
Learn more
GlyCare™ 3SL
Learn more
GlyCare™ 6SL
Learn more
GlyCare™ LNFP I/2FL
Learn more
GlyCare™ 3FL
Learn more
Download our product brochure to learn more.
Download brochure
Your end-to-end partner for HMO innovation
Beyond ingredients, it takes a partner to achieve the most ambitious product goals. To help support optimal infant development and health outcomes during and beyond early life, dsm-firmenich is spearheading innovation in the field of HMOs. Our extensive range of HMOs is complemented by a broad portfolio of science-backed products and customized solutions. In addition, our regulatory expertise and comprehensive range of expert services provide tailored support across the entire product life cycle – from concept to consumer. Get in touch to discover how we can co-create your next HMO innovation.
Partner with us
References
- Bode L. Human milk oligosaccharides: every baby needs a sugar mama.Glycobiology.2012;22(9):1147-1162.
- Francesca Turroni, Christian Milani, Marco Ventura, Douwe van Sinderen. The human gut microbiota during the initial stages of life: insights from bifidobacteria, Current Opinion in Biotechnology. 2022; 73:81-87.
- Gensollen T, Iyer SS, Kasper DL, Blumberg RS.How colonization by microbiota in early life shapes the immune system.Science.2016;352(6285):539-544.
- Bode L. Human milk oligosaccharides: every baby needs a sugar mama.Glycobiology.2012;22(9):1147-1162.
- Bode L. Human milk oligosaccharides: every baby needs a sugar mama.Glycobiology.2012;22(9):1147-1162.
- Walsh, C., Lane, J.A., van Sinderen, D.et al.Human milk oligosaccharide-sharing by a consortium of infant derivedBifidobacteriumspecies.Sci Rep.2022;12:4143.
- Di Mauro A, Neu J, Riezzo G, et al. Gastrointestinal function development and microbiota.Ital J Pediatr.2013;39:15.
- Saavedra JM, Dattilo AM. Early development of intestinal microbiota: implications for future health.Gastroenterol Clin North Am.2012;41(4):717-731.
- Bode L. Human milk oligosaccharides: every baby needs a sugar mama.Glycobiology.2012;22(9):1147-1162.
Related Articles
- It takes guts and science: Unlock the latest research behind human milk oligosaccharides (HMOs) for human health
Health & Nutrition
- Supporting the infant microbiome: Exploring the science of synergistic synbiotics at ESPGHAN 2024
Health & Nutrition
- dsm-firmenich secures UK and EU approvals for 3-FL and LNFP-I/2'-FL human milk oligosaccharide ingredients
HMOs
More than ingredients
Learn how DSM can help your business. Select the options below to connect your needs with the right solution.
I'd like to explore...
New product concept
Sample request
Quote request
Connect to an expert
If the options above don't sound like you, skip ahead andcontact us.
Quick Links
Premix Solutions
Customized blends of desired functional ingredients in one single, efficient, hom*ogenous premix.
Solutions to address consumers' health and lifestyle needs.
Market-ready Solutions
Streamline your product development process and get to market faster.
dsm-firmenich.com
We're innovators in nutrition, health, and beauty. And we bring progress to life!
Talking Nutrition
Explore new science, consumer insights, industry events and more.
Customer Portal
Request samples, place orders and view product documentation.